Diagnosis and Treatment of Agoraphobia with Panic Disorder

  title={Diagnosis and Treatment of Agoraphobia with Panic Disorder},
  author={Giulio Perugi and Franco Frare and Cristina Toni},
  journal={CNS Drugs},
Agoraphobia with panic disorder is a phobic-anxious syndrome where patients avoid situations or places in which they fear being embarrassed, or being unable to escape or get help if a panic attack occurs. During the last half-century, agoraphobia has been thought of as being closely linked to the recurring panic attack syndrome, so much so that in most cases it appears to be the typical development or complication of panic disorder.Despite the high prevalence of agoraphobia with panic disorder… 
Assessment of Panic Disorder Across the Life Span
An overview of various screening and assessment tools used to evaluate panic disorder across the lifespan is provided and some of the developmental differences and variability in the clinical presentation of pediatric and geriatric panic disorder are highlighted.
A survey on phobia - An anxiety disorder
A fear is a sort of nervousness issue characterized by an industrious and exorbitant dread of an article or circumstance. The influenced individual may encounter a wide range of side effects.[1] Fear
Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition
Recent evidence on pharmacological treatments of agoraphobia is summarized and discussed, based on clinical trials available from 2000, with the aim of highlighting pharmacotherapies that may improve this complex syndrome.
Comparison studies of antidepressants currently used for the treatment of panic disorder suggest selective serotonin reuptake inhibitors and venlafaxine should be considered as first line agents because their clinical efficacy is as high as those observed with other classes of antidepressants but they are associated with a significantly lower likelihood of side effects.
Agoraphobia: a review of the diagnostic classificatory position and criteria
It is come to the conclusion that AG should be conceptualized as an independent disorder with more specific criteria rather than a subordinate, residual form of panic disorder as currently stipulated in DSM‐IV‐TR.
Evaluation of a practice team-supported exposure training for patients with panic disorder with or without agoraphobia in primary care - study protocol of a cluster randomised controlled superiority trial
A practice team-supported, self-managed exposure programme for patients with panic disorder with or without agoraphobia in small general practices is compared to usual care in terms of clinical efficacy and cost-effectiveness.
Self-guided digital treatment with virtual reality for panic disorder and agoraphobia: a study protocol for a randomized controlled trial
If successful, this approach might be a feasible and promising way to ease the burden of PD, AG, and PDA on the public health system and contribute to a faster access to treatment.
Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder.
The Brazilian Medical Association guidelines are proposed to serve as a reference for the general practitioner and specialist to assist in and facilitate the diagnosis of panic disorder.
First conceptualized in the 1960s, the term culture-bound disorders refers to a classification of mental disorders or syndromes that are considered specific or closely related to cultural factors and


Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
An initial nonspontaneous first panic attack and separation anxiety was associated with earlier onset and longer duration of agoraphobia and panic disorder, and an inaccurate cognitive appraisal of the initial panic attack frequently led to the rapid development of subsequent agorphobia.
Hypochondriasis and illness phobia in panic-agoraphobic patients.
Panic: Course, Complications and Treatment of Panic Disorder
The SSRI sertraline appears effective not only in improving symptoms of panic, but also in reducing anticipatory anxiety and improving multiple aspects of quality of life.
Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Alprazolam was effective in reducing panic and depressive symptomatology in both depressed and nondepressed subjects with panic disorder and subjects with or without depression responded similarly to alprazoam.
Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
Patients with panic disorder or agoraphobia with panic attacks who had been placed on a regimen of tricyclic antidepressant treatment 1 to 4 years earlier reported at least moderate improvement during treatment; however, side effects were often difficult to tolerate, and 35% discontinued tricycleclic treatment on this account.
Prodromal symptoms in panic disorder with agoraphobia.
The results indicate that phobic avoidance in panic disorder with agoraphobia may not be secondary to the panic attacks, a finding that runs counter to the current DSM-III-R classification of anxiety disorders.
Long-Term Effects of Behavioural Treatment for Panic Disorder with Agoraphobia
Exposure treatment can provide lasting relief for the majority of patients and Disappearance of residual and subclinical agoraphobic avoidance, and not simply of panic attacks, should be the aim of exposure therapy.
Remission and Relapse in Subjects with Panic Disorder and Panic with Agoraphobia: A Prospective Short-Interval Naturalistic Follow-Up
The results are consistent with the view that panic disorder has a chronic course with high rates of relapse after remission and longer episodes when agoraphobia is a part of the constellation of symptoms.